PENTAX
Report
- Report Number
- 9610877-2021-10477
- Event Type
- Malfunction
- Date Received
- July 21, 2021
- Date of Event
- March 9, 2021
- Report Date
- September 7, 2021
- Manufacturer
- HOYA CORPORATION PENTAX OFFICE
- Product Code
- FCY
- PMA / PMN Number
- K131902
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
DURING PENTAX INTERNAL REVIEW IT WAS DISCOVERED ON AUGUST 21, 2021 THAT THE EVENT WAS NOT REPORTABLE BUT FILED UNDER MDR (9610877-2021-10477) WHICH WAS SUBMITTED ON JULY 21, 2021. THIS COMPLAINT IS NOT REPORTABLE TO U.S. FDA BECAUSE SHA-P5 LEAK TESTER, MANUFACTURED BY PENTAX, IS DISTRIBUTED BY PENTAX ONLY IN OUS COUNTRIES (OUTSIDE OF THE U.S.). PENTAX DOES NOT DISTRIBUTE A SIMILAR DEVICE MANUFACTURED BY PENTAX. PENTAX DISTRIBUTES ZUTRON LEAKAGE TESTERS IN THE U.S. MANUFACTURED BY ZUTRON MEDICAL (OEM).THIS REPORT IS BEING FILED AS PART OF THE PENTAX BACKLOG MANAGEMENT PLAN.
DURING PENTAX INTERNAL REVIEW IT WAS DISCOVERED ON AUGUST 21, 2021 THAT THE EVENT WAS NOT REPORTABLE BUT FILED UNDER MDR (9610877-2021-10477) WHICH WAS SUBMITTED ON JULY 21, 2021. THIS COMPLAINT IS NOT REPORTABLE TO U.S. FDA BECAUSE SHA-P5 LEAK TESTER, MANUFACTURED BY PENTAX, IS DISTRIBUTED BY PENTAX ONLY IN OUS COUNTRIES (OUTSIDE OF THE U.S.). PENTAX DOES NOT DISTRIBUTE A SIMILAR DEVICE MANUFACTURED BY PENTAX. PENTAX DISTRIBUTES ZUTRON LEAKAGE TESTERS IN THE U.S. MANUFACTURED BY ZUTRON MEDICAL (OEM).THIS REPORT IS BEING FILED AS PART OF THE PENTAX BACKLOG MANAGEMENT PLAN.
EVALUATION SUMMARY: IT WAS CAUSED DUE TO A MALFUCTION ON THE DEVICE. IT WAS NON-REPAIR ITEM SO THAT IT WAS REPLACED WITH NEW ONE. THIS REPORT IS BEING FILED AS PART IF THE PENTAX BACKLOG MANAGEMENT PLAN.
THIS EVENT OCCURED AT THE TIME OF REPROCESSING. THERE WAS NO REPORT OF PATIENT HARM. THE LEAK TESTER DOES NOT HELD THE PRESSURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1099439 | PENTAX | LEAKAGE TESTER | FCY | HOYA CORPORATION PENTAX OFFICE | SHA-P5 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |